STOCK TITAN

Avantor SEC Filings

AVTR NYSE

Welcome to our dedicated page for Avantor SEC filings (Ticker: AVTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to Avantor, Inc. (NYSE: AVTR) SEC filings, offering a view into the company’s financial reporting, governance updates and material events. Avantor is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries, and its regulatory filings document key aspects of this business.

Through Forms 10-K and 10-Q, readers can review Avantor’s audited annual and quarterly financial statements, along with management’s discussion of results, risk factors and segment information. Current reports on Form 8-K capture material developments such as quarterly earnings announcements, leadership and board changes, amendments to credit facilities, and other significant transactions. For example, recent 8-K filings describe the appointment of a new President and Chief Executive Officer, the creation of an Executive Vice President and Chief Operating Officer role, the election of new independent directors, and amendments to senior secured credit facilities and the termination of an accounts receivable securitization facility.

Avantor’s filings also explain the company’s use of non-GAAP financial measures, including Adjusted Operating Income, Adjusted EBITDA, adjusted net income, adjusted EPS, adjusted net leverage, free cash flow and free cash flow conversion, and provide reconciliations to comparable GAAP measures. Investors can use these disclosures to understand how management evaluates performance and capital structure.

On this page, Stock Titan pairs real-time EDGAR updates with AI-powered summaries that highlight the main points in each filing. Users can quickly identify items related to quarterly results, financing arrangements, governance changes and other topics, while still having access to the full original documents for detailed review.

Rhea-AI Summary

Avantor (AVTR) insider filing: The company’s EVP, Bioscience Production reported a Form 4 transaction on 10/02/2025. The filing shows 1,264 shares of common stock were withheld by the issuer at $13.77 under code F, which reflects shares retained to satisfy tax withholding in connection with RSU vesting. Following this administrative withholding, the reporting person directly holds 235,684 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.78%
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.78%
Tags
current report
-
Rhea-AI Summary

Gregory L. Summe, a director of Avantor, Inc. (AVTR), reported insider transactions dated 08/21/2025. The Form 4 shows a purchase of 100,000 shares of Avantor common stock at a weighted average price of $12.56 per share and a reported disposition of 58,111 shares. After the purchase, the reporting person discloses beneficial ownership of 200,000 shares held by a trust, with a disclaimer of ownership except for his pecuniary interest. The filing was signed by Scott Baker by power of attorney on 08/22/2025. The filing does not include option or derivative transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Avantor, Inc. director and President & CEO Emmanuel Ligner was granted equity on 08/18/2025. The filing reports 195,924 restricted stock units issued with vesting in three equal installments beginning 08/18/2026 and stock options to purchase 573,394 shares with an exercise price of $14.04, vesting in three equal annual installments beginning 08/18/2026 and expiring 08/18/2035. Following the reported transactions, Mr. Ligner beneficially owns 195,924 shares (direct) and 573,394 shares underlying options (direct). The Form 4 was signed by a power of attorney on 08/21/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Emmanuel Ligner filed an Initial Statement of Beneficial Ownership (Form 3) reporting his relationship to Avantor, Inc. (ticker AVTR) as President and CEO and a director. The date of the event requiring the statement is 08/18/2025. The filing states no securities are beneficially owned by the reporting person. The submission was signed on behalf of Mr. Ligner by Scott Baker under power of attorney on 08/21/2025. The form is filed by one reporting person and contains no holdings or derivative positions disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Insider transaction disclosure for Avantor, Inc. (AVTR). Brittany Hankamer, EVP and Chief HR Officer, reported a withholding transaction on 08/14/2025 related to vested restricted stock units. The form shows 181 shares were withheld by the issuer to satisfy tax withholding at an effective price of $12.98 per share. After the withholding, Ms. Hankamer beneficially owned 171,563 shares, held directly. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 08/15/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Avantor, Inc. elected Emmanuel Ligner as a director, with an initial term commencing on August 18, 2025 and expiring at the company’s 2026 Annual Meeting of Stockholders. The Board selected Mr. Ligner to fill a vacant seat and the company disclosed that he will receive no additional compensation for his service on the Board. The company noted that Mr. Ligner will begin serving as President and Chief Executive Officer as previously reported.

The filing references prior disclosure of his employment terms and states that an employment contract dated July 15, 2025 between VWR International Ltd., a subsidiary, and Mr. Ligner will be filed with the quarterly report for the period ending September 30, 2025. The company also reported there are no arrangements or understandings with other persons about his selection and that he has no direct or indirect material interest in transactions requiring disclosure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Summary: Dodge & Cox filed a Schedule 13G/A reporting beneficial ownership of 117,433,484 shares of Avantor, representing 17.2% of the class. The filer reports sole voting power over 111,093,684 shares and sole dispositive power over 117,433,484 shares.

The filing discloses that clients of Dodge & Cox, including the Dodge & Cox Stock Fund, have the right to dividends and proceeds; the Stock Fund holds 74,871,715 shares ( 11.0%). Dodge & Cox certifies these securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Avantor insider reporting: Christophe Couturier, listed as Executive Vice President, AMEA, received a grant of restricted stock units that vest on 08/08/2027. The Form 4 shows an acquisition of 65,217 shares (reported as an award), bringing his total beneficial ownership to 211,271 shares. The filing also notes 1,140 shares held from the Avantor Employee Stock Purchase Plan.

The disclosure is a routine equity award for an officer rather than a market transaction, increasing the officer's stake through time‑based vesting. The record lists the transaction as an acquisition through restricted stock units and specifies the vesting date without additional conditions in the filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Form 4 summary: Steven W. Eck, SVP & Chief Accounting Officer of Avantor, Inc. (AVTR), reported a sale of 3,476 shares of common stock on 08/05/2025 at a price of $11.39 per share. Beneficial ownership following the reported transaction is 55,068 shares. The Form 4 was signed by attorney-in-fact Scott Baker on 08/06/2025. No derivative securities are reported on Table II.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Avantor (AVTR)?

The current stock price of Avantor (AVTR) is $11.07 as of February 2, 2026.

What is the market cap of Avantor (AVTR)?

The market cap of Avantor (AVTR) is approximately 7.4B.
Avantor

NYSE:AVTR

AVTR Rankings

AVTR Stock Data

7.45B
657.56M
1.37%
106.68%
4.4%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
RADNOR

AVTR RSS Feed